English

89bio, Inc.

EDGAR

ETNB Quarterly report (10-Q) · filed 2025-08-08

54 filing records in this dataset, filed from 2019-10-11 to 2025-08-08. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 129 million USD 2025-06-30 Source
Exact value

129076000 USD
Long-term debt including current maturities: 36.2 million USD 2025-06-30 Source
Exact value

36156000 USD
Shares outstanding: 148 million shares 2025-06-30 Source
Exact value

148304875 shares

Reported share-count change

41.36% · 43.4 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

104915176 shares · 2024-06-30· Source
148304875 shares · 2025-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-450 million USD

2024-07-01 – 2025-06-30

Exact inputs and evidence

Net income: -149073000 USD · 2024-07-01 – 2024-09-30 Source
Net income: -367079000 USD · 2024-01-01 – 2024-12-31 Source
Net income: -248725000 USD · 2024-01-01 – 2024-09-30 Source
Net income: -71275000 USD · 2025-01-01 – 2025-03-31 Source
Net income: -111504000 USD · 2025-04-01 – 2025-06-30 Source

Operating cash flow

-439 million USD

2024-07-01 – 2025-06-30

Exact inputs and evidence

Operating cash flow: -246243000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -100884000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -367823000 USD · 2024-01-01 – 2024-12-31 Source
Operating cash flow: -246243000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -71737000 USD · 2025-01-01 – 2025-03-31 Source
Operating cash flow: -172162000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -71737000 USD · 2025-01-01 – 2025-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-08-08.

Financial data available through: 2024-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 7 of 11 periods available· newest 2024-12-31
Net income: 7 of 11 periods available· newest 2024-12-31
Operating cash flow: 7 of 11 periods available· newest 2024-12-31
Capital expenditure: 7 of 11 periods available· newest 2024-12-31
Total assets: 7 of 11 periods available· newest 2024-12-31
Total liabilities: 5 of 11 periods available· newest 2024-12-31
Current assets: 7 of 11 periods available· newest 2024-12-31
Current liabilities: 7 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2024-12-31
Long-term debt including current maturities: 3 of 11 periods available· newest 2024-12-31
Shares outstanding: 7 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 224.89 million

Prior period

−USD 142.19 million

2023-01-01 – 2023-12-31
Current period

−USD 367.08 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-367079000 − -142189000 = -224890000 USD

-142189000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-367079000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · 89bio, Inc. · 2024-12-31 89bio, Inc. (edgar:1785173) Year-over-year change in Net income: -224890000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -367079000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1593527 Filing: 000095017025029243 Input fundies:NetIncome: -142189000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1489698 Filing: 000095017025029243
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 238.64 million

Prior period

−USD 129.19 million

2023-01-01 – 2023-12-31
Current period

−USD 367.82 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-367823000 − -129186000 = -238637000 USD

-129186000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-367823000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · 89bio, Inc. · 2024-12-31 89bio, Inc. (edgar:1785173) Year-over-year change in Operating cash flow: -238637000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -367823000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1699473 Filing: 000095017025029243 Input fundies:OperatingCashFlow: -129186000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1701234 Filing: 000095017025029243
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+275%

Prior period

USD 4,000

2023-01-01 – 2023-12-31
Current period

USD 15,000

2024-01-01 – 2024-12-31

Exact inputs and evidence

15000 − 4000 = 11000 USD

4000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
15000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · 89bio, Inc. · 2024-12-31 89bio, Inc. (edgar:1785173) Year-over-year change in Capital expenditure: 11000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 15000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1719044 Filing: 000095017025029243 Input fundies:CapitalExpenditure: 4000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1720791 Filing: 000095017025029243
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-18 – 2018-12-31	−USD 16.18 million Exact value Exact value: -16176000 USD 2018-01-18 – 2018-12-31: -16176000 USD Inspect Net Income Open source Share or cite Citation for Net Income · 89bio, Inc. · 2018-12-31 89bio, Inc. (edgar:1785173) Net Income: -16176000 USD Concept: fundies:NetIncome Period: 2018-01-18 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-18&unit=USD&dimensions= Input fundies:NetIncome: -16176000 USD (2018-01-18 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459020011636/etnb-20191231.xml#116736 Filing: 000156459020011636 The citation records this snapshot. The page link may show a newer release later.	−USD 12.47 million Exact value Exact value: -12469000 USD 2018-01-18 – 2018-12-31: -12469000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 89bio, Inc. · 2018-12-31 89bio, Inc. (edgar:1785173) Operating Cash Flow: -12469000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-18 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-18&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12469000 USD (2018-01-18 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459020011636/etnb-20191231.xml#143629 Filing: 000156459020011636 The citation records this snapshot. The page link may show a newer release later.	USD 39,000 Exact value Exact value: 39000 USD 2018-01-18 – 2018-12-31: 39000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · 89bio, Inc. · 2018-12-31 89bio, Inc. (edgar:1785173) Capital Expenditure: 39000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-18 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-18&unit=USD&dimensions= Input fundies:CapitalExpenditure: 39000 USD (2018-01-18 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459020011636/etnb-20191231.xml#144050 Filing: 000156459020011636 The citation records this snapshot. The page link may show a newer release later.	−USD 12.51 million Calculation and evidence -12469000 − 39000 USD Exact free cash flow: -12508000 USD 2018-01-18 – 2018-12-31: -12469000 USD · Inspect Operating Cash Flow · Source 2018-01-18 – 2018-12-31: 39000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · 89bio, Inc. · 2018-12-31 89bio, Inc. (edgar:1785173) Free cash flow: -12508000 USD Concept: free-cash-flow Period: 2018-01-18 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12469000 USD (2018-01-18 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459020011636/etnb-20191231.xml#143629 Filing: 000156459020011636 Input fundies:CapitalExpenditure: 39000 USD (2018-01-18 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459020011636/etnb-20191231.xml#144050 Filing: 000156459020011636 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-19 – 2018-12-31	−USD 16.18 million Exact value Exact value: -16176000 USD 2018-01-19 – 2018-12-31: -16176000 USD Inspect Net Income Open source Share or cite Citation for Net Income · 89bio, Inc. · 2018-12-31 89bio, Inc. (edgar:1785173) Net Income: -16176000 USD Concept: fundies:NetIncome Period: 2018-01-19 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-19&unit=USD&dimensions= Input fundies:NetIncome: -16176000 USD (2018-01-19 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459020011636/etnb-20191231.xml#126758 Filing: 000156459020011636 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	−USD 57.42 million Exact value Exact value: -57420000 USD 2019-01-01 – 2019-12-31: -57420000 USD Inspect Net Income Open source Share or cite Citation for Net Income · 89bio, Inc. · 2019-12-31 89bio, Inc. (edgar:1785173) Net Income: -57420000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -57420000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459021015214/etnb-20201231.xml#114429 Filing: 000156459021015214 The citation records this snapshot. The page link may show a newer release later.	−USD 25.46 million Exact value Exact value: -25460000 USD 2019-01-01 – 2019-12-31: -25460000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 89bio, Inc. · 2019-12-31 89bio, Inc. (edgar:1785173) Operating Cash Flow: -25460000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25460000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459021015214/etnb-20201231.xml#138741 Filing: 000156459021015214 The citation records this snapshot. The page link may show a newer release later.	USD 139,000 Exact value Exact value: 139000 USD 2019-01-01 – 2019-12-31: 139000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · 89bio, Inc. · 2019-12-31 89bio, Inc. (edgar:1785173) Capital Expenditure: 139000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 139000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459021015214/etnb-20201231.xml#139613 Filing: 000156459021015214 The citation records this snapshot. The page link may show a newer release later.	−USD 25.6 million Calculation and evidence -25460000 − 139000 USD Exact free cash flow: -25599000 USD 2019-01-01 – 2019-12-31: -25460000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 139000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · 89bio, Inc. · 2019-12-31 89bio, Inc. (edgar:1785173) Free cash flow: -25599000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25460000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459021015214/etnb-20201231.xml#138741 Filing: 000156459021015214 Input fundies:CapitalExpenditure: 139000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459021015214/etnb-20201231.xml#139613 Filing: 000156459021015214 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 49.5 million Exact value Exact value: -49499000 USD 2020-01-01 – 2020-12-31: -49499000 USD Inspect Net Income Open source Share or cite Citation for Net Income · 89bio, Inc. · 2020-12-31 89bio, Inc. (edgar:1785173) Net Income: -49499000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -49499000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459022011706/etnb-10k_20211231.htm#1435612 Filing: 000156459022011706 The citation records this snapshot. The page link may show a newer release later.	−USD 46.24 million Exact value Exact value: -46244000 USD 2020-01-01 – 2020-12-31: -46244000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 89bio, Inc. · 2020-12-31 89bio, Inc. (edgar:1785173) Operating Cash Flow: -46244000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -46244000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459022011706/etnb-10k_20211231.htm#1603812 Filing: 000156459022011706 The citation records this snapshot. The page link may show a newer release later.	USD 126,000 Exact value Exact value: 126000 USD 2020-01-01 – 2020-12-31: 126000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · 89bio, Inc. · 2020-12-31 89bio, Inc. (edgar:1785173) Capital Expenditure: 126000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 126000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459022011706/etnb-10k_20211231.htm#1619693 Filing: 000156459022011706 The citation records this snapshot. The page link may show a newer release later.	−USD 46.37 million Calculation and evidence -46244000 − 126000 USD Exact free cash flow: -46370000 USD 2020-01-01 – 2020-12-31: -46244000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 126000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · 89bio, Inc. · 2020-12-31 89bio, Inc. (edgar:1785173) Free cash flow: -46370000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -46244000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459022011706/etnb-10k_20211231.htm#1603812 Filing: 000156459022011706 Input fundies:CapitalExpenditure: 126000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000156459022011706/etnb-10k_20211231.htm#1619693 Filing: 000156459022011706 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 90.12 million Exact value Exact value: -90122000 USD 2021-01-01 – 2021-12-31: -90122000 USD Inspect Net Income Open source Share or cite Citation for Net Income · 89bio, Inc. · 2021-12-31 89bio, Inc. (edgar:1785173) Net Income: -90122000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -90122000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017024024008/etnb-20231231.htm#1190523 Filing: 000095017024024008 The citation records this snapshot. The page link may show a newer release later.	−USD 76.78 million Exact value Exact value: -76781000 USD 2021-01-01 – 2021-12-31: -76781000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 89bio, Inc. · 2021-12-31 89bio, Inc. (edgar:1785173) Operating Cash Flow: -76781000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -76781000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017024024008/etnb-20231231.htm#1432867 Filing: 000095017024024008 The citation records this snapshot. The page link may show a newer release later.	USD 63,000 Exact value Exact value: 63000 USD 2021-01-01 – 2021-12-31: 63000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · 89bio, Inc. · 2021-12-31 89bio, Inc. (edgar:1785173) Capital Expenditure: 63000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 63000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017024024008/etnb-20231231.htm#1448545 Filing: 000095017024024008 The citation records this snapshot. The page link may show a newer release later.	−USD 76.84 million Calculation and evidence -76781000 − 63000 USD Exact free cash flow: -76844000 USD 2021-01-01 – 2021-12-31: -76781000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 63000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · 89bio, Inc. · 2021-12-31 89bio, Inc. (edgar:1785173) Free cash flow: -76844000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -76781000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017024024008/etnb-20231231.htm#1432867 Filing: 000095017024024008 Input fundies:CapitalExpenditure: 63000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017024024008/etnb-20231231.htm#1448545 Filing: 000095017024024008 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 102.03 million Exact value Exact value: -102026000 USD 2022-01-01 – 2022-12-31: -102026000 USD Inspect Net Income Open source Share or cite Citation for Net Income · 89bio, Inc. · 2022-12-31 89bio, Inc. (edgar:1785173) Net Income: -102026000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -102026000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1394080 Filing: 000095017025029243 The citation records this snapshot. The page link may show a newer release later.	−USD 81.09 million Exact value Exact value: -81090000 USD 2022-01-01 – 2022-12-31: -81090000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 89bio, Inc. · 2022-12-31 89bio, Inc. (edgar:1785173) Operating Cash Flow: -81090000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -81090000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1702995 Filing: 000095017025029243 The citation records this snapshot. The page link may show a newer release later.	USD 7,000 Exact value Exact value: 7000 USD 2022-01-01 – 2022-12-31: 7000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · 89bio, Inc. · 2022-12-31 89bio, Inc. (edgar:1785173) Capital Expenditure: 7000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1722537 Filing: 000095017025029243 The citation records this snapshot. The page link may show a newer release later.	−USD 81.1 million Calculation and evidence -81090000 − 7000 USD Exact free cash flow: -81097000 USD 2022-01-01 – 2022-12-31: -81090000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 7000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · 89bio, Inc. · 2022-12-31 89bio, Inc. (edgar:1785173) Free cash flow: -81097000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -81090000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1702995 Filing: 000095017025029243 Input fundies:CapitalExpenditure: 7000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1722537 Filing: 000095017025029243 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 142.19 million Exact value Exact value: -142189000 USD 2023-01-01 – 2023-12-31: -142189000 USD Inspect Net Income Open source Share or cite Citation for Net Income · 89bio, Inc. · 2023-12-31 89bio, Inc. (edgar:1785173) Net Income: -142189000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -142189000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1489698 Filing: 000095017025029243 The citation records this snapshot. The page link may show a newer release later.	−USD 129.19 million Exact value Exact value: -129186000 USD 2023-01-01 – 2023-12-31: -129186000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 89bio, Inc. · 2023-12-31 89bio, Inc. (edgar:1785173) Operating Cash Flow: -129186000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -129186000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1701234 Filing: 000095017025029243 The citation records this snapshot. The page link may show a newer release later.	USD 4,000 Exact value Exact value: 4000 USD 2023-01-01 – 2023-12-31: 4000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · 89bio, Inc. · 2023-12-31 89bio, Inc. (edgar:1785173) Capital Expenditure: 4000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1720791 Filing: 000095017025029243 The citation records this snapshot. The page link may show a newer release later.	−USD 129.19 million Calculation and evidence -129186000 − 4000 USD Exact free cash flow: -129190000 USD 2023-01-01 – 2023-12-31: -129186000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 4000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · 89bio, Inc. · 2023-12-31 89bio, Inc. (edgar:1785173) Free cash flow: -129190000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -129186000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1701234 Filing: 000095017025029243 Input fundies:CapitalExpenditure: 4000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1720791 Filing: 000095017025029243 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 367.08 million Exact value Exact value: -367079000 USD 2024-01-01 – 2024-12-31: -367079000 USD Inspect Net Income Open source Share or cite Citation for Net Income · 89bio, Inc. · 2024-12-31 89bio, Inc. (edgar:1785173) Net Income: -367079000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -367079000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1593527 Filing: 000095017025029243 The citation records this snapshot. The page link may show a newer release later.	−USD 367.82 million Exact value Exact value: -367823000 USD 2024-01-01 – 2024-12-31: -367823000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 89bio, Inc. · 2024-12-31 89bio, Inc. (edgar:1785173) Operating Cash Flow: -367823000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -367823000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1699473 Filing: 000095017025029243 The citation records this snapshot. The page link may show a newer release later.	USD 15,000 Exact value Exact value: 15000 USD 2024-01-01 – 2024-12-31: 15000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · 89bio, Inc. · 2024-12-31 89bio, Inc. (edgar:1785173) Capital Expenditure: 15000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1719044 Filing: 000095017025029243 The citation records this snapshot. The page link may show a newer release later.	−USD 367.84 million Calculation and evidence -367823000 − 15000 USD Exact free cash flow: -367838000 USD 2024-01-01 – 2024-12-31: -367823000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 15000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · 89bio, Inc. · 2024-12-31 89bio, Inc. (edgar:1785173) Free cash flow: -367838000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:38:45Z Snapshot: adc86e137c1d5c1728af1c8dd6f7a4365ff3883d721ec927eeb3c935682b348d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1785173?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -367823000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1699473 Filing: 000095017025029243 Input fundies:CapitalExpenditure: 15000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm#1719044 Filing: 000095017025029243 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

54 filings · 1,540 latest values · 1,540 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001785173, 1785173, ETNB, edgar:1785173

Also known as 89bio, Inc.

89bio, Inc.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation